Earth Science Tech (ETST) Marks Growth as Avenvi Expands Asset Base
Earth Science Tech (ETST) reported revenue growth to $35.7M in FY2026, up from $33.1M in FY2025 and $11.95M in FY2024. Gross profit also increased to $25.5M. The company attributes its success to strategic acquisitions, including Avenvi, which adds real estate assets and financial services to ETST's healthcare and telemedicine operations.
How this was made

The 30-second read
Why it matters
The disclosed growth and acquisition provide fresh data for valuation models and may influence short‑term trading decisions.
Market read
Primary micro‑cap news with modest relevance for OTC investors; limited broader market effect.
What to watch
Potential regulatory or integration risks of merging real‑estate and healthcare businesses.
Background
ETST is an OTC‑listed diversified holding company in health and wellness, reporting FY2026 growth and a strategic acquisition.
Ticker impact
ETST disclosed FY2026 revenue of $35.7M, a rise from $33.1M YoY, and announced acquisition of Avenvi, adding real‑estate assets.
Potential modest price appreciation if market views the acquisition as value‑adding.
Growth numbers are modest and the company remains micro‑cap; the deal is small‑scale but adds diversification.
Market effects
Highlights continued consolidation in the health‑wellness and real‑estate niche for micro‑caps.
Limited to U.S. OTC market; no broader regional effect.
Minimal global impact due to company size.
Counterpoint
The acquisition may dilute focus on core pharmacy operations and strain capital without clear revenue upside.
Key entities
- companyEarth Science Tech Inc.
OTC‑listed holding company focusing on health and wellness.
- companyAvenvi
Private real‑estate firm acquired by ETST.
